Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 9Thoracic 5Myeloid 5Gastrointestinal 5Genitourinary 4Gynecologic 3Dermatologic 2Tumor-Agnostic 1Sarcoma 1Endocrine 1CNS 1

Conditions

Melanoma 2Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Specimen Handling 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
guadecitabine × Dermatologic × Clear all
NCT04250246 2020-01-31

NIBIT-ML1

Italian Network for Tumor Biotherapy Foundation

Phase 2 Unknown
184 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02608437 2015-11-18

NIBIT-M4

Italian Network for Tumor Biotherapy Foundation

Phase 1 Unknown
19 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡